Pharmaceutical contaminants in water are a growing risk, warns the Water Research Commission
With the 12 specialised key population clinics in South Africa funded by the US government, and now shuttered, getting treatment at government clinics has been difficult, if not…
Today, people over 50 make up the second largest group of South Africa’s HIV-positive population — 20 years ago, they were the smallest proportion
Donald Trump’s funding freeze underlines that South Africa needs to prioritise the development of its pharmaceutical manufacturing sector
Babies getting HIV from their infected mothers is rare in a cluster of 39 villages in the OR Tambo district
The Bulungula Incubator in the Eastern Cape has set up a medicine pick up point close to people’s homes, assisting them in sticking to their treatment
ARV drug dolutegravir will become the go-to drug in all treatment plans next year. Here are 7 things you should know
Treatment Action Campaign and other civil society groups forced a reluctant Mbeki government to change its stance and roll out ARVs
Wealthy countries were quick to ban Southern African nations from entering their borders when the Omicron variant was identified, but did not do so to each other.
New research from seven countries in Africa signals the future of HIV prevention — but what can it learn from its past?
Let us please not repeat the devastating Aids story where people died of shame rather than admit being infected by the virus
Despite the long history of medical racism, any potential Covid-19 vaccines must be tested in Africa — but not only on the continent
The HIV prevention tablet is now available in South Africa but popping a pill every day to stay HIV-negative may not be for everyone
They’re not only good for workers’ health, they’re good for business too.
The purpose of the research was to look at the health and wellbeing of public schools, with specific focus on the HIV profile of school leadership
The country has made progress with its plans to prevent, treat and monitor HIV but still has a long way to go.
Science knows more than ever about how to use HIV treatment to prevent new infections but will it be enough to end Aids?
Researchers predict that in 2040, low-income countries will spend just $0.03 on healthcare for every dollar that high-income countries spend.
Truvada, which contains two antiretrovirals, reduces the risk of HIV infection with up to 96%.
A survey of stock levels of HIV drugs is in stark contrast to health department claims that "there is no shortage".
